Liu et al. in a meta-analysis of thirty case-control studies, showed that NOD2 polymorphism was associated with an increased risk of gastric, breast, laryngeal, MALT lymphoma, lung and colorectal cancer [16]. This evidence concerns the gene NOD2 and MALT lymphoma.